MorphoSys AG
MorphoSys AG MOR.SW Peers
See (MOR.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MOR.SW | CHF 102.00 | -100.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| BION.SW | CHF 30.70 | -0.49% | 1.7B | 13.41 | CHF 2.29 | +5.86% |
| KURN.SW | CHF 24.80 | -0.48% | 951.9M | -248.00 | -CHF 0.10 | N/A |
| BSLN.SW | CHF 49.20 | +6.15% | 603.8M | 8.44 | CHF 5.83 | N/A |
| IDIA.SW | CHF 2.00 | N/A | 407.6M | -1.44 | -CHF 1.39 | N/A |
| SANN.SW | CHF 13.14 | -0.15% | 169.1M | -3.56 | -CHF 3.69 | N/A |
| NWRN.SW | CHF 7.32 | N/A | 146.1M | 9.15 | CHF 0.80 | N/A |
| MOLN.SW | CHF 2.95 | -2.64% | 108.8M | -1.74 | -CHF 1.70 | N/A |
| RLF.SW | CHF 2.21 | -3.91% | 27.8M | -1.62 | -CHF 1.36 | N/A |
| ADXN.SW | CHF 0.06 | +1.42% | 10M | -1.14 | -CHF 0.05 | N/A |
Stock Comparison
MOR.SW vs BION.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, BION.SW has a market cap of 1.7B. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while BION.SW trades at CHF 30.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas BION.SW's P/E ratio is 13.41. In terms of profitability, MOR.SW's ROE is +2.47%, compared to BION.SW's ROE of +0.03%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and BION.SW has daily volatility of 1.14.
MOR.SW vs KURN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, KURN.SW has a market cap of 951.9M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while KURN.SW trades at CHF 24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas KURN.SW's P/E ratio is -248.00. In terms of profitability, MOR.SW's ROE is +2.47%, compared to KURN.SW's ROE of -0.07%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and KURN.SW has daily volatility of 2.10.
MOR.SW vs BSLN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, BSLN.SW has a market cap of 603.8M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while BSLN.SW trades at CHF 49.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas BSLN.SW's P/E ratio is 8.44. In terms of profitability, MOR.SW's ROE is +2.47%, compared to BSLN.SW's ROE of +1.59%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and BSLN.SW has daily volatility of 6.64.
MOR.SW vs IDIA.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, IDIA.SW has a market cap of 407.6M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while IDIA.SW trades at CHF 2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas IDIA.SW's P/E ratio is -1.44. In terms of profitability, MOR.SW's ROE is +2.47%, compared to IDIA.SW's ROE of +0.24%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and IDIA.SW has daily volatility of 11.72.
MOR.SW vs SANN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SANN.SW has a market cap of 169.1M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SANN.SW trades at CHF 13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SANN.SW's P/E ratio is -3.56. In terms of profitability, MOR.SW's ROE is +2.47%, compared to SANN.SW's ROE of -1.11%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SANN.SW has daily volatility of 4.13.
MOR.SW vs NWRN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, NWRN.SW has a market cap of 146.1M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while NWRN.SW trades at CHF 7.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas NWRN.SW's P/E ratio is 9.15. In terms of profitability, MOR.SW's ROE is +2.47%, compared to NWRN.SW's ROE of +1.28%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and NWRN.SW has daily volatility of 2.86.
MOR.SW vs MOLN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, MOLN.SW has a market cap of 108.8M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while MOLN.SW trades at CHF 2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas MOLN.SW's P/E ratio is -1.74. In terms of profitability, MOR.SW's ROE is +2.47%, compared to MOLN.SW's ROE of -0.36%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and MOLN.SW has daily volatility of 2.87.
MOR.SW vs RLF.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, RLF.SW has a market cap of 27.8M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while RLF.SW trades at CHF 2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas RLF.SW's P/E ratio is -1.62. In terms of profitability, MOR.SW's ROE is +2.47%, compared to RLF.SW's ROE of -0.40%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and RLF.SW has daily volatility of 5.31.
MOR.SW vs ADXN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, ADXN.SW has a market cap of 10M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while ADXN.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas ADXN.SW's P/E ratio is -1.14. In terms of profitability, MOR.SW's ROE is +2.47%, compared to ADXN.SW's ROE of +0.88%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and ADXN.SW has daily volatility of 5.15.
MOR.SW vs EVE.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, EVE.SW has a market cap of 8.2M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while EVE.SW trades at CHF 1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas EVE.SW's P/E ratio is 8.14. In terms of profitability, MOR.SW's ROE is +2.47%, compared to EVE.SW's ROE of +0.13%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and EVE.SW has daily volatility of 8.28.
MOR.SW vs SPEX.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, MOR.SW's ROE is +2.47%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SPEX.SW has daily volatility of 13.08.
MOR.SW vs OBSN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, MOR.SW's ROE is +2.47%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and OBSN.SW has daily volatility of 131.43.
MOR.SW vs SKIN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, MOR.SW's ROE is +2.47%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SKIN.SW has daily volatility of 11.76.
MOR.SW vs POLN.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, MOR.SW's ROE is +2.47%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and POLN.SW has daily volatility of 7.16.
MOR.SW vs GILD.SW Comparison
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, GILD.SW has a market cap of 0. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while GILD.SW trades at CHF 66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas GILD.SW's P/E ratio is N/A. In terms of profitability, MOR.SW's ROE is +2.47%, compared to GILD.SW's ROE of +0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and GILD.SW has daily volatility of 0.00.